Sociedad Americana de Hirudoterapia

The role of vein grafts in reconstructive head and neck microsurgery

Research article published in Brazilian journal of otorhinolaryngology (2022)

Última actualización: 1 de noviembre de 2026Revisado por: ASH Editorial Board
Artículo de investigación — revisión de la evidenciaReferencia del artículo
Evidencia: Informe de investigaciónLiteratura clínicaLai et al. · Brazilian journal of otorhinolaryngology, 2022

Resumen

OBJECTIVE: Free tissue transfer is widely used for head and neck reconstruction. In certain circumstances, vein grafting is required to elongate free flap pedicles to connect them to appropriate recipient vessels. Because of controversy regarding the use of interposition vein grafts in free tissue reconstruction, this paper reports vein graft indications, techniques, safety, and outcomes for head and neck microvascular surgery. METHODS: Twenty-six patients (23 men and 3 women) who underwent interposition vein grafting concurrent with free tissue transfer were included in this study. The most common reason for head and neck reconstruction with vein graft was tumor recurrence, followed by flap salvage. The interposition vein grafts were applied in two manners as temporary arteriovenous (A-V) loop and conduit to extend the length of the free flap for venous drainage. RESULTS: The most common reconstructions were anterolateral thigh flaps (15 cases), followed by vastus lateralis myocutaneous (3 cases) and radial forearm (2 cases) flaps. The common recipient vessels were superior thyroid artery, superficial temporal artery and external jugular vein. The free flap loss rate was 7.7% with vein grafts and 4.9 without vein grafts (p = 0.380). The free flap complication rate was 50.0% and 16.8% in patients with and without vein grafts, respectively (p < 0.001). Radiation therapy, chemotherapy, prior neck dissection, and prior free flap transfer were more common in the vein graft group (all p < 0.001). The hospital stay was significantly longer for the vein graft group than for the non-vein graft group (29.5 vs. 19.0 days; p = 0.001). CONCLUSION: Overall free flap survival rates of 92.3% and 95.1% in the vein and non-vein graft groups, respectively - indicating the reliability of the vein grafts in challenging head and neck reconstructions, particularly in salvage cases and patients with multiple reconstructions. LEVEL OF EVIDENCE: Level 3.

Resumen tomado de PubMed (NCBI) para el registro citado, en el idioma original. La versión de referencia es la de la publicación original.

El resumen se deja sin traducir para conservar la redacción original de los autores.

Tipo de publicaciónJournal Article
Términos MeSH indexadosMaleHumansFemaleReproducibility of ResultsHead and Neck NeoplasmsNeoplasm Recurrence, LocalMicrosurgeryFree Tissue FlapsRetrospective Studies

Síntesis

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Citación

Referencia (estilo Vancouver)

Lai CS, Chang YT, Shen CH, Tsai YC, Lu CT, Yen JH, et al. The role of vein grafts in reconstructive head and neck microsurgery. Braz J Otorhinolaryngol. 2022;88 Suppl 4(Suppl 4):S81-S88. doi:10.1016/j.bjorl.2021.09.004. PMID: 34802968

Los datos bibliográficos (autores, volumen, páginas, DOI) proceden del registro de PubMed.

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Investigación relacionada

Más estudios revisados por pares en la categoría «Literatura clínica».

Ver toda la investigación analizada por la ASH →

Añadido a la biblioteca ASH: 28 de mayo de 2026 · Última actualización del sitio: 1 de noviembre de 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.